Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Reexamination Certificate
2007-02-27
2007-02-27
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
C568S003000, C560S008000
Reexamination Certificate
active
10866179
ABSTRACT:
The invention provides novel non-β-lactam inhibitors of β-lactamases. In particular, the invention provides boronic acid-based compounds set forth in the specification. These compounds may be used with β-lactam antibiotics to bacterial infection, particularly, β-lactam-antibiotic-resistant bacterial infections. These compounds are also antibacterial agents by themselves. The invention further provides methods of using such compounds. Finally, the invention provides a pharmaceutical composition comprising these compounds.
REFERENCES:
patent: 6075014 (2000-06-01), Weston et al.
patent: 6417174 (2002-07-01), Shoichet et al.
Freire Ernesto
Luque Irene
Ottenbrite Raphael
Ross Patrick
Xiao Yingxin
Chu Yong
Darby & Darby
Fulcrum Pharmaceuticals Inc.
McKane Joseph K.
The Johns Hopkins University
LandOfFree
β-lactamase inhibitors and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β-lactamase inhibitors and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β-lactamase inhibitors and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828667